Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P.

Nat Med. 2002 Aug;8(8):831-40. Epub 2002 Jul 1.

PMID:
12091877
2.

Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.

Luttun A, Tjwa M, Carmeliet P.

Ann N Y Acad Sci. 2002 Dec;979:80-93. Review.

PMID:
12543719
3.
5.
6.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
7.

Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis.

Breier G.

Adv Exp Med Biol. 2000;476:57-66. Review. No abstract available.

PMID:
10949655
8.

The role of vascular endothelial growth factor in angiogenesis.

Ferrara N, Gerber HP.

Acta Haematol. 2001;106(4):148-56. Review.

PMID:
11815711
9.

Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.

Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S.

Med Sci Monit. 2000 Sep-Oct;6(5):1047-52. Review.

PMID:
11208453
10.

Structure and function of placental growth factor.

De Falco S, Gigante B, Persico MG.

Trends Cardiovasc Med. 2002 Aug;12(6):241-6. Review.

PMID:
12242046
11.

Role of VEGF-flt receptor system in normal and tumor angiogenesis.

Shibuya M.

Adv Cancer Res. 1995;67:281-316. Review. No abstract available.

PMID:
8571818
12.

VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.

Nagy JA, Dvorak AM, Dvorak HF.

Trends Cardiovasc Med. 2003 Jul;13(5):169-75. Review.

PMID:
12837578
13.
14.

Lymphatic versus blood vascular endothelial growth factors and receptors in humans.

Partanen TA, Paavonen K.

Microsc Res Tech. 2001 Oct 15;55(2):108-21. Review.

PMID:
11596156
15.

Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.

Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR.

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):233-5. Review.

PMID:
7542074
16.

The placenta growth factor in skin angiogenesis.

Odorisio T, Cianfarani F, Failla CM, Zambruno G.

J Dermatol Sci. 2006 Jan;41(1):11-9. Epub 2005 Oct 10. Review. Erratum in: J Dermatol Sci. 2004 Jul;43(1):71.

PMID:
16216466
17.
18.

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Fischer C, Mazzone M, Jonckx B, Carmeliet P.

Nat Rev Cancer. 2008 Dec;8(12):942-56. doi: 10.1038/nrc2524. Review.

PMID:
19029957
19.

VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.

Tjwa M, Luttun A, Autiero M, Carmeliet P.

Cell Tissue Res. 2003 Oct;314(1):5-14. Epub 2003 Sep 10. Review.

PMID:
13680354
20.

The discovery of placenta growth factor and its biological activity.

De Falco S.

Exp Mol Med. 2012 Jan 31;44(1):1-9. doi: 10.3858/emm.2012.44.1.025. Review.

Supplemental Content

Support Center